| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.1B | $0.1B | $0.1B | $-0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| EPS (Basic) | $6.71 | $5.97 | $6.95 | $-0.71 | $1.74 | $1.42 | $0.95 | $0.77 |
| EPS (Diluted) | $6.62 | $5.93 | $6.91 | $-0.71 | $1.69 | $1.39 | $0.93 | $0.75 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $8.3B | $7.3B | $7.1B | $6.3B | $7.1B | $4.3B | $3.4B | $2.2B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $0.4B | $0.2B | $0.3B | $0.3B | $2.4B | $0.9B | $0.4B | $0.2B |
| Total Liabilities | $7.5B | $6.6B | $6.4B | $5.7B | $6.6B | $4.0B | $3.1B | $1.9B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $0.7B | $0.7B | $0.7B | $0.6B | $0.6B | $0.3B | $0.3B | $0.3B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.1B | $0.1B | $0.0B | $0.1B | $0.0B | $0.1B | $0.0B | $0.0B |
| Investing Cash Flow | $-0.8B | $-0.4B | $-0.8B | $-1.2B | $-1.3B | $-0.5B | $-1.0B | $-0.5B |
| Capital Expenditures | — | — | — | — | — | — | — | $0.0B |
| Financing Cash Flow | $0.9B | $0.2B | $0.7B | $-1.0B | $2.8B | $0.9B | $1.1B | $0.4B |